Clinical Trial: A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomized Open Label Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).
Brief Summary:
Klebsiella pneumonia, inhabitant of the digestive tract, is a frequent nosocomial pathogen. It is currently the fourth most common cause of pneumonia and fifth most common cause of bacteremia in intensive care patients (1-3).
The aim of the present randomized controlled trial is to assess the efficacy of non-absorbable oral antibiotics in the eradication of the KPC carrier state.
Detailed Summary:
Sponsor: Rambam Health Care Campus
Current Primary Outcome: The specific measure that will be used to determine the effect of the intervention(s): eradication rate (%). [ Time Frame: twice a week ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Rambam Health Care Campus
Dates:
Date Received: December 23, 2010
Date Started: July 2009
Date Completion:
Last Updated: April 26, 2017
Last Verified: April 2017